SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-23-060891
Filing Date
2023-05-15
Accepted
2023-05-15 16:54:32
Documents
6
Period of Report
2023-06-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2315787d1_def14a.htm DEF 14A 445873
2 GRAPHIC image_003.jpg GRAPHIC 264303
3 GRAPHIC image_004.jpg GRAPHIC 281029
4 GRAPHIC tm2315787d1_def14aimg002.jpg GRAPHIC 12505
5 GRAPHIC tm2315787d1_def14aimg003.jpg GRAPHIC 31261
6 GRAPHIC tm2315787d1_def14aimg004.jpg GRAPHIC 34912
  Complete submission text file 0001104659-23-060891.txt   1307190
Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
First Wave BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 464993860 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37853 | Film No.: 23923789
SIC: 2834 Pharmaceutical Preparations